Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Timing matters: study tests best moment to remove dead tissue in pancreatitis

NCT ID NCT05530772

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at 50 adults with infected, walled-off dead tissue in the pancreas from severe pancreatitis. Researchers compared doing endoscopic removal right away versus waiting until needed. The goal was to see which approach leads to complete recovery and fewer complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Endoscopic necrosectomy (a procedure using an endoscope to remove dead tissue from the pancreas)
What this could lead to
If immediate necrosectomy works better, it could shorten hospital stays and reduce the number of procedures needed for patients with infected pancreatic necrosis.
What could go wrong
This is a small, single-center study with only 50 participants, so results may not apply to all patients. The procedure carries risks like bleeding, infection, or perforation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

50 people

The number who actually took part.

Started

Sep 2022

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Documented history of acute pancreatitis * Necrotic collection with partial or complete wall diagnosed on CT or MRI * Necrotic collection of any size with any number of loculations with more than 20% of solid/necrotic component * Necrotic collection is accessible and amenable for EUS-guided drainage * Age \>= 18 years * Suspected or confirmed infection in the necrotic collection * The patient understands and accepts to sign the informed consent. Exclusion Criteria: * Irreversible coagulopathy with INR\>1.5 or platelet counts \<50,000 * Necrotic collection is not accessible for EUS-guided drainage * Females who are pregnant * Previous intervention (e,g, percutaneous drainage, or surgery) is performed for the patient

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pancreatitis, acute necrotizing are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

acute necrotizing pancreatitis Pancreatitis, Acute Necrotizing

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Digestive Diseases Research Institute, Shariati Hospital, North Kargar Ave.,

    Tehran, Tehran Province, 1411713135, Iran

More trials for these conditions

Other studies related to the condition(s) this trial covers.